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Abstract
Background: This research paper will discuss the surgical management and possible mechanisms, as well as
enlighten other features which can explain meningioma and astrocytoma simultaneously occurrences including
statistical coincidence, the role of common carcinogens, autocrine growth factors and their pathogenic correlations.
Case presentation: We describe two patients with simultaneous presentation of meningioma with astrocytoma. A
correct preoperative radiological diagnosis was made in both patients and their tumors were completely removed
microscopically. Pathological examinations confirmed that one among them was meningioma and the other an
anaplastic astrocytoma. We reviewed the studies carried out regarding meningioma associated with astrocytoma in
China as well as in other countries.
Conclusion: In the absence of phacomatosis or prior radiation therapy, the reason for the simultaneous occurrence
of astrocytoma with meningioma is not clear, and these tumors could be merely a statistical coincidence. Careful
preoperative radiological evaluation and surgical management is of great importance in these patients.
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Background
Meningioma and astrocytoma are two common primary
brain tumors, which commonly occur as solitary lesions.
They have a nearly contrary clinical outcome because of
their distinctive biological behaviors. The simultaneous
occurrence of meningioma and gliotic tumors or even col-
lision tumors are mainly observed in some phacomatosis
such as von Recklinghausen neurofibromatosis, and in sev-
eral other genetic syndromes such as Turcot’s and Sipple’s
syndrome, and also after cranial radiotherapy [1, 2]. In this
article, we report two cases with simultaneous meningioma
and astrocytoma occurrence in the same patients without
radiotherapy, phacomatosis, or any genetic disorders.
The aim of this study is to define surgical management
and the etiopathogenic correlations of meningioma
with astrocytoma.
Case presentation
An overview of the patients clinical data is given in Table 1.
Case 1
The 48-year-old woman was presented with weakness of
the left upper limb that has developed over six months.
This patient had a generalized seizure, a sudden nausea
and vomiting four hours before admission. The neuro-
logical examination revealed 4/5 left hemiparesis with
out any other abnormality. The patient’s blood type was
AB positive and the preoperative Karnofsky Performance
Score (KPS) was 80. The patient’s family history was
unremarkable and there were no cutaneous markers in
her skin. Cranial Magnetic Resonance Imaging (MRI)
revealed a right parietal lobe meningioma. In the right
temporal lobe, a low-grade glioma with large edema was
found (Fig. 1).
Under general anesthesia, right parietal craniotomy was
performed. The parietal lobe meningioma was completely
resected microscopically. One day after surgery, the
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patient presented drowsiness and her pupils were seen to
be bilaterally fixed at 3.5 mm with less reaction to light.
She was discharged with 0/5 full muscle strength in the
left extremities. The non-contrast Computed Tomography
(CT) showed intratumoral hemorrhage localized on the
right temporal region and midline shifting to the left
side (Fig. 2). Under general anesthesia, the patient
underwent gross resection of the right temporal tumor
at the second stage. An intraoperative frozen section
examination confirmed the pathological diagnosis as
malignant glioma.
All tissue samples for pathological study were fixed in
10 % buffered formalin. Microscopic sections generated
from routinely processed paraffin blocks were stained with
Hematoxylin and Eosin (H&E). Immunohistochemistry
was performed with the following panel of antibodies: Epi-
thelial Membrane Antigen (EMA), Glial Fibrillary Acidic
Protein (GFAP), CD34, Vimentin (Vim), Ki-67, CD57, CK,
S-100 protein, and Olig-2.
The histopathological report confirmed the presence
of a transitional meningioma with fibroblastic tissue and
whorls of meningothelial cells with few psammoma bod-
ies. The right temporal lesion was hypercellular paren-
chyma consisting of pleomorphic astrocytic cells with
thrombosis. There was no evidence of vascular prolifera-
tion or necrosis (Fig. 3). Immunohistochemistry results
and major biomarkers are summarized in Table 2.
One month later, the patient’s postoperative KPS was 70.
The patient experienced an increase in her hemiparesis in
the postoperative period and underwent radiation therapy
(60 Gy) in conjunction with daily temozolomide (75 mg/
m2/day) for 42 days followed by a 4-month course of
temozolomide (200 mg/m2 for 5 days per 28-day cycle). She
tolerated the adjuvant therapy well. However, the patient
was lost to follow-up five months after the first surgery.
Case 2
A 65-year-old man had presented with speech difficulty
and walking instability about one day before admission.
The patient was fully oriented and without any neurological
deficits. The patient had no history of a neurocutaneous
disorder, previous head trauma, surgery or irradiation of
the head. The patient’s family history concerning any prece-
dence in neurofibromatosis was reported as negative. The
patient’s blood type was A positive and preoperative KPS
was 90. Pre-operative non- contrast CT scan showed the
right frontal falx meningioma with calcification and a left
frontal mass lesion. MRI disclosed a right frontal falx
meningioma and the left frontal, corpus callosum high-
grade glioma (Fig. 4).
Under general anesthesia, a bicoronal incision with
right frontal and left frontal craniotomy was performed.
Meningioma and astrocytoma were totally removed. The
left frontal, corpus callosum surgical specimen consisted
Table 1 Clinical data of two reported cases
Patient 1 Patient 2
Age 48 66
Gender female male
Clinical presentation generalized epileptic seizure dysphasia
Spatial relationship of two tumors same hemisphere different hemisphere
Radiological diagnosis MRI CT,MRI
Treatment two-stage removal irradiation, chemotherapy one-sage removalirradiation, chemotherapy
WHO grading of Meningioma type WHO I, transitional WHO I, psammomatous
WHO grading Astrocytoma type WHO III, anaplastic WHO III, anaplastic
Outcome(survival after first surgery, months) 5(lost to follow-up) 8
Fig. 1 Pre-operative MRI of patient one. Marked large edema is appreciated in the T2-weighted modus (a). T1-weighted images with gadolinium
contrast. A coronary (b) and sagittal (c) views showed the right parietal lobe meningioma and the right temporal lobe low-grade glioma
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of several white to grayish, rubbery in consistency, soft
tissue, totaling about 4.5 cm × 4.5 cm × 1.6 cm. Whereas,
resection fragments derived from the right frontal tumor
were grayish and added up to 4 cm× 3 cm× 1.5 cm (Fig. 5).
A psammomatous meningioma WHOIand anaplastic
astrocytoma WHO III were diagnosed by hematoxylin and
eosin staining and immunohistological examination (Fig. 6).
Immunohistochemistry results and major biomarkers are
summarized in Table 2. Post-operative CT and MRI
demonstrated tumor residual cavity (Fig. 7).
The patient’s postoperative KPS score was 90. During
the following two months, the patient received external
beam radiotherapy with 59.4 Gy and two complete cycle
of temozolomide. Before starting the third cycle, routine
MRI revealed tumor recurrence four months after first
surgery. The patient refused further surgical intervention
and received gamma-knife surgery and three further
cycles of temozolomide at another hospital. The patient
did not recover from his neurological symptoms and
died 8 months after the first intervention.
Discussion
Primary central nervous system neoplasms may be multi-
focal including a small percentage of gliomas in the setting
of von Hippel-Lindau disease, and meningioma in the
setting of neurofibromatosis [3, 4]. The simultaneous or
even collision occurrence of primary intracranial tumors
without neurofibromatosis II and cranial radiotherapy is
reported infrequently. Meningioma has an increased
probability of developing another primary or secondary
brain tumor. Meningioma is the most common central
nervous system tumor to host a metastatic cancer [5, 6].
Among them, the simultaneous or coexistence of an
intracranial meningioma and an astrocytoma seems to
be one of the most commonly encountered type of
tumor [7–9].
We have reviewed the literature and found cases of
concurrent astrocytoma and meningioma similar to our
cases, excluding brain injury, phacomatosis or genetic
disorders and cranial radiotherapy (Table 3).
The etiology of this phenomenon remains unknown.
Multiple theories have been postulated in the literatures for
the simultaneous or collision occurrence of these tumors.
However, the exact mechanism underlying this observation
is yet to be defined. Exposure to biochemical substances,
genetic factors, prior trauma or surgery and immunological
mechanisms may be the causative or contributory factors
in the development of these tumors [3, 10].
Some studies believe that such cases are largely inci-
dental in their nature [11]. Meningioma is relatively a
common tumor of the CNS constituting about 18 % of
brain tumors. Similarly, glioma accounts for 40-50 % of
primary brain tumors [12]. The incidence of multiple
intracranial tumors of different histology is 10–15 cases
per 100,000 who develop primary brain tumors [13], and
from a statistical perspective chances of recurrence in
the same patient is possible. Meningioma and glioma,
whether they exist together or separate are relatively
common forms of neoplasms involving the brain, and
their concurrence in many cases maybe coincidental.
Many genetic factors may also be involved and a genetic
study in such cases with this condition is advisable [14].
Another theory suggests that, astrocytoma may develop
due to neoplastic transformation of the reactive glial cells
surrounding a meningioma [1, 15, 16]. Juxtaposition of
these diverse germinal origin tumors in the same patient
suggests that one tumor may act as an irritating agent for
the local proliferation and growth of the other. Growth of
Fig. 3 Hematoxylin and eosin (H&E) staining showing the results of
pathological examinations of patient one (a and b). Photomicrograph
a showing a tumor composed of meningothelial cells in whorls.
Photomicrograph b showing malignant astrocytoma with
hypercellularity and nuclear plemorphism (H&E × 400, medium power)
Fig. 2 Post-operative CT of patient one. One day after first surgery non-contrast computed tomographic (CT) axial view showing intratumoral
hemorrhage localized on the right temporal region (a and b). Six hours after second stage surgery CT showing right temporal lobe mass lesion
was removed (c)
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human tumors cell in these cases follows autocrinous
mechanism. Among RTK signaling molecules, it has been
suggested that expression of platelet-derived growth factor
receptor (PDGFR) is involved in the tumorigenesis and
malignant progression of meningioma [17], and the most
suspected substance is platelet-derived growth factor
(PDGF) [16]. Three subunits of PDGF, the PDGF-AA,
PDGF-BB and PDGF-AB,are secreted by astrocytoma
[18]. There are two types of PDGF receptors: PDGF-α-R
and PDGF-β-R, and the latter is found in meningioma.
Astrocytoma has PDGF-α-R receptor and their growth is
stimulated by PDGF in an autocrine fashion. PDGF-BB
acting via this receptor increases c-fos level and also men-
ingioma cell division [16]. PDGFB is known to induce
oligodendroglia tumors in a mouse model without 1p/19q
loss of heterozygosity (LOH) [19]. Thus, astrocytoma may
stimulate growth in adjacent cells by production of com-
mon growth factors. Kengo Suzuki et al. [20], immunohis-
tochemically showed that platelet-derived growth factor
(PDGF) receptors-α and β were overexpressed in glio-
blastoma multiform meningioma, thereby indicating the
oncogenic effects of activated signaling of these receptors.
This hypothesis let us speculate that the collision tumor
might have been caused by malignant transformation of
the reactive gliosis surrounding the meningioma. How-
ever, this theory fails to explain why this transformation
happened in this particular case and not in the vast major-
ity of intracranial meningioma. This hypothesis also fails
to explain the simultaneous occurrence in some cases
with the two tumors far apart from each other.
The development and progression of meningioma and
glioma is likely to be involved in common genes [21]. Espe-
cially in collision tumors, in which the neoplasia grows with
mixed tumor matrices, the histological picture suggests a
common pathogenetic pathway. There may be a potential
common “pathogenetichits” site for astrocytoma and men-
ingioma. Identified as N-myc downstream-regulated gene
2(NDRG2), it was commonly activated in clinically aggres-
sive meningioma [22]. Recently, down-regulation of the
NDRG2 gene on 14q was shown to be associated with a
higher WHO grade and a clinically more aggressive course
[22]. An earlier research showed that this same gene was
expressed in normal brain tissue but down regulated in
glioma [23]. Thus, inactivation of NDRG 2 may play a role
in the pathogenesis of both meningioma and glioma.
Nestler U et al. [24], displayed the result of comparative
genomic hybridization (CGH) and chromosome analysis in
two patients who presented with glioblastoma simultan-
eously with meningioma. They believe that, genetic models
that could explain the progression of meningioma into
glioblastoma do not exist. In their case, they did not find a
common genetic aberration in tumor cells with a different
histology. Although the two tumor types were adjacent,
pathological examinations did not show the invasion
between the tumors in all reported cases. Therefore, it is
believed that this collision or simultaneous tumor might
have formed by chance.
A small handful of case reports describing trauma pre-
cedes the occurrence of the glioma at the same brain loca-
tion. Central nervous system injury initiates reactive gliosis
Table 2 Immunohistochemical results and major biomarkers of the two reported cases
EMA GFAP CD34 Vim Ki67% CD57 CK S-100 Olig-2
Case 1 meningioma + - + - 1 - - -
astrocytoma - + + + 10 +
Case 2 meningioma + - + 1 -
astrocytoma + + + - + +
-, none to weak; +, intermediate; ++, strong; ±, occasional
Fig. 4 Computed tomography (CT) and magnetic resonance imaging (MRI) images of patient one. Pre-operative non- contrast computed tomog-
raphy (CT) scan shows the right frontal falx meningioma with calcification and left frontal mass lesion (axial view) (a). T1-weighted images with
gadolinium contrast. Coronary (b) and sagittal (c) views showed the right frontal falx meningioma and the left frontal and corpus callosum
high-grade glioma
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and angiogenesis. Fibroblast growth factor-2 is overex-
pressed in the injured brain. The factor is implicated in
both transition of quiescent astrocytes to proliferation and
the neoplastic transformation of glioma cells [25, 26]. A
few cases of meningioma after trauma have been reported
[27]. The occurrence of glioma has been reported after
trauma [28]. One of these three case had an obvious
history of the observed collision of astrocytoma and men-
ingioma occurred 30 years after the trauma [8]. Therefore,
it appears that trauma might play a role in the formation
of collision or simultaneous tumors. There were no previ-
ous histories of trauma in both patients in our cases.
Careful preoperative radiological evaluation and an
apt operation strategy are of great importance in these
patients. The problems related to the simultaneous
occurrence of meningioma with astrocytoma concern
the correct preoperative diagnosis. Low-density areas
surrounding meningioma usually represent peritumoral
edema and exceptionally a low-grade astrocytoma [29].
An intraoperative biopsy of the brain tissue surround-
ing a meningioma should be performed in doubtful
cases [8]. An enlarging brain hypointensity around a
meningioma after removal of meningioma during the
follow-up may also suggest a biopsy. Jun P et al. [30],
demonstrated how pMRI (dynamic, contrast enhanced,
susceptibility-weighted perfusion MR imaging) could
identify regions of hemodynamic differences between 2
unique tissue types that were not apparent on conven-
tional anatomic MR imaging. Thus, perfusion MR
imaging may be helpful to distinguish collision tumors
negative on conventional anatomic MR imaging.
The surgical management of meningioma is undoubt-
edly influenced by the presence of astrocytoma. When the
two lesions are contiguous, they usually were removed in
a one-stage operation with no or little additional surgical
risk [1]. In our first case, we simply followed the stand-
point that the lesion causing the main neurological symp-
toms should be removed first, whether it is a meningioma
or an astrocytoma. We also thought that, after removal of
meningioma at first stage, we would avoid postoperative
brain swelling due to resection of malignant astrocytoma.
However, in our first case, after removal of meningioma,
intratumoral hemorrhage appeared in the astrocytoma.
This patient had no medical co-morbidities such as arter-
ial hypertension, trauma, coagulopathy and intraoperative
anesthetic complications. This means that the causal
relationship between surgery and this complication can be
rated as highly probable. We suggest that the two lesions
should be removed at one stage, when they are closely
situated. In our second case, we used one-stage removal of
two tumors. We did not know whether this surgical man-
agement could create significant brain decompression and
improve the quality of life in this kind of patients.
When the two tumors are distant from each other,
glioma must be removed, because the outcome depends
on its evolution. Meningioma is considered symptomatic
Fig. 5 Surgical specimen of patient two (a and b). The left frontal and corpus callosum surgical specimen (a). The right frontal tumor fragments
with the left frontal surgical specimen (b)
Fig. 6 Hematoxylin and eosin (H&E) staining showing the results of
pathological examinations of patient two (a and b). Psammomatous
meningioma WHO I (a) and Anaplastic astrocytoma WHO III (b)
(H&E × 400, medium power)
Fig. 7 Post-operative computed tomography (CT) and magnetic
resonance imaging (MRI) images patient two. Immediately
postoperative CT (a) and MRI (b) axial views, demonstrate tumor
residual cavity
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Table 3 Reported cases of simultaneous or collision astrocytoma and meningioma






Pathological diagnosis Treatment (after first
operation. month)
1 F.Maiuri et al.
[1]. (2005)
68 F Flax (posterior third
left)
Right temporal Asymptomatic (T.I.A with
ischemia)
MRI Low-grade astrocytoma Two-stage
removal (12 mo.)
2 65 M Flax (anterior
third left)
Left-frontal Generalized epileptic seizure CT WHO grade II astrocytoma One-stage removal,
irradiation
3 Goyal et al.
[31] (2003)





Two-stage removal (10 day)
4 Prayson et al.
[3] (2002)





5 Spallone et al.
[7] (1991)






CT Astrocytoma (WHO II)
Psammomatous meningioma
Two-stage removal (15 month)
chemotherapyirradiation
6 48 F Cavernous sinus Left
paraventricular




7 Dario. A et al.
[9] (1995)
58 F Parietal parasagittal Right temporal Progressive mental
deterioration seizures
CT Anaplastic astrocytoma Two-stage removal (22 mon.)
8 Arnetoli. G et al.
[32] (1983)








9 Khalatbari et al.
[33] (2010)




Headache nausea seizures MRI Anaplastic astrocytoma
(WHO grade III)
One-stage removal
10 Tokunaga, T., et al.
[34] (1991)
69 F Right parietal lobe Right parietal
convexity





11 Zhang et al.
[35] (2015)



















with a tendency to grow and easily accessible by surgery
and large to warrant surgical decompression. A second
stage craniotomy for removal of the meningioma may be
advisable when the patient is free from progression of
glioma. There is a need for conservative management for
the patient who is asymptomatic and with a small size or
deeply located meningioma and has an established glio-
blastoma. One may leave the meningioma the place where
it occurs, thus decreasing potential morbidity caused by
surgical treatment. The short expected life span of patient
with glioblastoma also precludes the need to remove the
meningioma. Small sized and incidental meningioma was
usually followed by periodical MRIs. More over, emphasis
should be on a concurrent asymptomatic, calcified, a
deep-located meningioma which may require a more
radical procedure for resection and place vital structures
at risk during treatment.
Conclusion
In the absence of phacomatosis or prior radiation therapy,
the reason for the simultaneous occurrence of astrocy-
toma with meningioma is not clear, and these tumors
could be merely a statistical coincidence. These cases were
not associated with phacomatosis and therapeutic radi-
ation. In addition, it would be valuable to study these
cases by molecular genetic techniques in the future.
Genetic testing of tumor cells in close proximity in the
brain will help to answer the questions of possible interac-
tions, common genetic pathways, or familial syndromes in
future.
Careful preoperative radiological evaluation and surgi-
cal management is of great importance in these patients.
One should take special attention to radiological evi-
dence of extraordinary brain edema at a distant site from
the meningioma. When these two lesions are closely
situated, the best way of surgical intervention is to
remove them in a one-stage operation. The management
priority for two tumors situated far apart from each
other may need case-by-case evaluation.
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